The Family Medicine Channel

Increased Risks of VTE and Mortality with Erythropoiesis-Stimulating Agents

1:05 | Family Medicine, Hospitalist, Internal Medicine, Oncology, Oncology / Hematology, Preventative Health, Surgery, Women’s Health

Erythropoiesis-stimulating agent administration to patients with cancer is associated with increased risks of VTE and mortality.

References and Resources
Bennett C., Silver S., Djulbegovic B., et al. Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia 2008. JAMA. 299(8):914-924.

More in Family Medicine

► 2:21:57

Virtual Conference: ISEH Adolescent Sports Medicine

Family Medicine

At the ISEH Adolescent Sports Medicine virtual conference, the speakers discussed common upper and lower limb problems, concussion management, and respiratory and breathing concerns in adolescents. Additional topics included managing...

► 1:04:07

The Reliability and Transferability of Current Randomized Controlled Trials Based on Real-World Evidence

Dermatology

Robert Kirsner, MD, PhD, University of Miami, Florida; Oscar M. Alvarez, PhD, Rutgers New Jersey Medical School, Newark, New Jersey; Vickie R. Driver, DPM, MS, INOVA Health System, Alexandria, Virginia;...

►

Physician Burnout: Addressing the Rapid Increase

Business of Medicine

Todd Unger, chief experience officer, AMA, and Christine Sinsky, MD, the AMA's vice president of professional satisfaction, discuss a recent study on physician burnout. Dr Sinsky explained that physician burnout...

► 58:01

Street Medicine: Why, What, How

Family Medicine

For the inaugural Macaran A. Baird, MD, Lecture in Family Medicine and Community Health Leadership, Jehni Robinson, MD, chair and clinical professor of the Department of Family Medicine and associate...